0001144204-16-106289.txt : 20160601 0001144204-16-106289.hdr.sgml : 20160601 20160601165023 ACCESSION NUMBER: 0001144204-16-106289 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160601 DATE AS OF CHANGE: 20160601 EFFECTIVENESS DATE: 20160601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biostage, Inc. CENTRAL INDEX KEY: 0001563665 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 455210462 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-264220 FILM NUMBER: 161689820 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: (774) 233-7300 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 FORMER COMPANY: FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc. DATE OF NAME CHANGE: 20121204 D 1 primary_doc.xml X0707 D LIVE 0001563665 Biostage, Inc. 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA MASSACHUSETTS 01746 (774) 233-7300 DELAWARE None Harvard Apparatus Regenerative Technology, Inc. Corporation true 2012 James McGorry 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Executive Officer Director President and CEO Thomas McNaughton 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Executive Officer Chief Financial Officer La Francesca Saverio 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Executive Officer EVP and Chief Medical Officer John Kennedy 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Director John Canepa 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Director Blaine McKee 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Director Thomas Robinson 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Director Biotechnology Decline to Disclose 06b false 2016-05-19 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVE. 4TH FLOOR NEW YORK NY NEW YORK 10022 CA CALIFORNIA IL ILLINOIS NJ NEW JERSEY NY NEW YORK TX TEXAS false 5000001 5000001 0 Excludes proceeds totaling up to $2,500,000 from the exercise of the warrants. false 5 350000 0 Excludes 141,844 placement agent warrants. Additionally, does not include [potential future compensation to placement agent regarding tail fees pursuant to future transactions. 0 Some of the proceeds may be used for working capital and other general corporate purposes, which may include the payment of salaries and other fees to those listed in Item 3. false Biostage, Inc. /s/ Thomas McNaughton Thomas McNaughton Chief Financial Officer 2016-06-01